Not Tagged
Not Tagged
['lymsm', 'lymphoma']
congress #asco22 | describes ahod1331 phase iii study of children+aya with advanced hl treated with bv+ave-pc vs ave-pc. n=600. median follow-up of 42.1 mos, 3-year efs was 82.5% with abve-pc &amp; 92.1% with bv-ave-pc #lymphoma #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm